Silicon Valley Life Sciences Summit
Questions? Please contact Amy Romaker, aromaker@sheppardmullin.com.
This summit will address issues that are of strategic importance to the continued growth and success of both emerging and established life sciences companies. This will be an invaluable opportunity to interact with legal experts and learn ways to protect your company’s interests. Attend all or a few of the following sessions.
Session One: 8:00 – 9:00 a.m.The Economic Crisis and What it Means to You: Capturing Distressed Biotech Opportunities. Learn ways to protect and finance your company when acquiring IP from distressed companies.
Presenter: Ed Tillinghast (Partner, New York), Kirt Shuldberg (Partner, San Diego)
Session Two: 9:15: – 10:00 a.m.
Good, Bad and Ugly: A Look Back at Patent Litigation in 2008. Come and learn about the most important patent litigation cases of 2008.
Presenters: Joy Arnold (Partner, New York), Jennifer Trusso (Partner, Orange County), Bhavna Joneja (Special Counsel, New York)
Session Three: 10:15 – 11:00 a.m.
Recent Trends in Drug Development Contracting and Risk Allocation: What Are Clinical Sites, CROs and Contract Manufacturers Asking For? Discuss how to protect your company from service providers mistakes.
Presenter: Blaine Templeman (Partner, New York)
Session Four: 11:15 – 12:00 noon
FDA’s Alphabet Soups Boils Over: A Look at Key FDA Issues for 2009 – FDAAA/REMS, FOBs, and DTC Advertising. Gain insight into FDA initiatives that will affect your business.
Presenter: Deborah Shelton (Special Counsel, Washington D.C.)